Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Prinses Máxima Centrum Voorpagina
Nederlands
English
!!Search content at Prinses Máxima Centrum
Voorpagina
Profielen
Onderzoeksgroepen
Uitrusting
Onderzoeksoutput
Prijzen
Activiteiten
Knipsels
Treatment of childhood acute myeloid leukemia
Edske ter Bals
,
Gertjan J.L. Kaspers
Onderzoeksoutput
:
Bijdrage aan tijdschrift
›
Artikel recenseren
›
Onderzoek
›
peer review
7
Citaten (Scopus)
Overzicht
Vingerafdruk
Vingerafdruk
Duik in de onderzoeksthema's van 'Treatment of childhood acute myeloid leukemia'. Samen vormen ze een unieke vingerafdruk.
Sorteer per
Gewicht
Alfabetische volgorde
Keyphrases
Childhood Acute Lymphoblastic Leukemia
100%
Targeted Therapy
66%
Pediatric Leukemia
66%
Malignancy
33%
Mechanism of Action
33%
Activating mutation
33%
Minimal Residual Disease
33%
Treatment Monitoring
33%
Survival Rate
33%
Acute Myeloid Leukemia
33%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
33%
Prognostic Factors
33%
Novel Agents
33%
Treatment Strategy
33%
Late Effects
33%
Young children
33%
Current Treatment
33%
Intensive Chemotherapy
33%
Quality of Life
33%
Receptor Tyrosine Kinase
33%
Stem Cell Transplantation
33%
Anticancer Agents
33%
Maintenance Treatment
33%
Age Groups
33%
Cranial Irradiation
33%
Tailored Therapy
33%
Supportive Care
33%
High-risk Population
33%
Tailored Treatment
33%
Late Effects of Cancer Treatment
33%
Children with Down Syndrome
33%
Acute Promyelocytic Leukemia
33%
CNS Prophylaxis
33%
Prophylaxis Treatment
33%
Reasonable Doubt
33%
Life Effects
33%
Treatment Therapies
33%
Biologic Features
33%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
High Risk Population
50%
Targeted Therapy
50%
Pediatric Acute Myeloid Leukemia
50%
Adolescence
50%
Cancer
25%
Minimal Residual Disease
25%
Survival Rate
25%
Prognostic Factor
25%
Down Syndrome
25%
Allogeneic Stem Cell Transplantation
25%
Quality of Life
25%
Protein Tyrosine Kinase
25%
Stem Cell Therapy
25%
Late Effect
25%
Supportive Care
25%
Maintenance Therapy
25%
Skull Irradiation
25%
Leukemia in Children
25%
Anticarcinogen
25%
Biological Product
25%
Patient Monitoring
25%
Acute Promyelocytic Leukemia
25%
Late Effect of Treatment
25%
Age Groups
25%
Diseases
25%
Chemotherapy
25%